- Trials with a EudraCT protocol (2,397)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
2,397 result(s) found.
Displaying page 1 of 120.
| EudraCT Number: 2007-003370-26 | Sponsor Protocol Number: CLAF237ADE03 | Start Date*: 2007-11-15 |
| Sponsor Name:Charite Universitätsmedizin Berlin | ||
| Full Title: A prospective, single center, double blind, placebo controlled study of adipocytokines, adipose tissue gene expression and hepatic insulin clearance in the therapeutic response to vildagliptin in man | ||
| Medical condition: This is a single center, randomized, double-blind pilot study on patients with Type 2 diabetes. The purpose of this study is to test the effects of vildagliptin (as add-on to metformin) on hepatic ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-005531-17 | Sponsor Protocol Number: Xe-01 | Start Date*: 2007-05-08 |
| Sponsor Name:Klinik für Anästhesiologie Universitätsklinikum Aachen | ||
| Full Title: Xenon als Antidepressivum | ||
| Medical condition: Major depressive disorder and recurrent mayor depressive disorder (ICD 10 F32.2 and 33.3) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-000569-13 | Sponsor Protocol Number: EMR 64300-608 | Start Date*: 2006-04-21 |
| Sponsor Name:Cardioangiologisches Centrum Bethanien | ||
| Full Title: Influence on the coronary Microcirculation and on myocArdial perfusion Reserve of Niaspan given IN addition to simvastatin in diabEtic patients | ||
| Medical condition: Diabetic patients at high risk for CVD | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002278-37 | Sponsor Protocol Number: panto001 | Start Date*: 2008-08-12 |
| Sponsor Name:Johann Wolfgang Goethe Universität | ||
| Full Title: Auswirkungen von Pantoprazol auf die myokardiale Kontraktilität bei Patienten mit Herzinsuffizienz - influence of pantoprazole on human myocardial contractility at patients with congestive heart fa... | ||
| Medical condition: Recently literature revealed facts, that show H+/K+ ATPase expression is not limited tot he stomach. H+/K+ ATPase was also found in smooth muscle cells and in other tissues (McCabe, R.D. et al., Am... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002284-13 | Sponsor Protocol Number: CRx-197-003 | Start Date*: 2009-01-19 |
| Sponsor Name:CombinatoRx, Incorporated | ||
| Full Title: A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY TO ASSESS THE ANTI-INFLAMMATORY PROPERTIES OF TOPICAL CRX-197 IN LESIONAL SKIN OF ADULT SUBJECTS WITH MILD TO MODERATE ATOPIC DERMATITIS | ||
| Medical condition: mild to moderate atopic dermatitis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-003116-22 | Sponsor Protocol Number: RBK091 | Start Date*: 2006-12-21 |
| Sponsor Name:Prof. Sechtem, Department of Cardiology, Robert Bosch Hospital | ||
| Full Title: Application of Sildenafil in patients with documented coronary vasospasm in order to explore the pathophysiology of coronary vasospasm and the therapeutic effects of Sildenafil in patients sufferin... | ||
| Medical condition: Coronary vasospasm is an abrupt severe vasoconstriction of coronary arteries leading to myocardial ischemia and angina pectoris. The reason for the occurrence of coronary spasm and the cellular mec... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002501-72 | Sponsor Protocol Number: Neo-WTS | Start Date*: 2005-01-31 |
| Sponsor Name: | ||
| Full Title: Studie zur neoadjuvanten Therapie bei Hochrisikopatienten mit Weichteilsarkom (STS) im Erwachsenenalter | ||
| Medical condition: Weichteilsarkome im Erwachsenenalter | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-000223-42 | Sponsor Protocol Number: ZiSe | Start Date*: 2005-10-31 |
| Sponsor Name:University Hospital Hamburg-Eppendorf, Psychiatry | ||
| Full Title: Effects of ziprasidone vs. placebo during the first four weeks of eight weeks sertraline treatment in patients with posttraumatic stress disorder (PTSD) | ||
| Medical condition: Post-traumatic Stress Disorder (PTSD) according to DSM-IV criteria | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-005060-24 | Sponsor Protocol Number: Chirocain 2010 | Start Date*: 2005-12-08 |
| Sponsor Name:Klinikum Leverkusen gGmbH | ||
| Full Title: Comparison of Levobupivacaine and Ropivacaine for epidural application in obstetric gynaecology | ||
| Medical condition: Comparison of Levobupivacaine and Ropivacaine for epidural application in obstetric gynaecology | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-005074-24 | Sponsor Protocol Number: Feb-02 | Start Date*: 2005-02-23 | |||||||||||
| Sponsor Name:Febena Pharma GmbH | |||||||||||||
| Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF AN OINTMENT FORMULATION CONTAINING DEXAMETHASONE IN PATIENTS WITH RHINOSINUSITIS A CLINICAL PHASE IV ... | |||||||||||||
| Medical condition: Patients with allergy-induced, non-infectious diseases of the nasal mucosa (e. g. hay fever) and the sinuses. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-005914-18 | Sponsor Protocol Number: APIDR_L_00465 | Start Date*: 2006-03-15 |
| Sponsor Name:Diabetes-Centre Quakenbrueck | ||
| Full Title: Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro | ||
| Medical condition: Obese subjects with type 2 diabetes mellitus | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002761-21 | Sponsor Protocol Number: ADO-Solaraze-AK-3-6 | Start Date*: 2005-08-08 |
| Sponsor Name:University Medical Center | ||
| Full Title: RANDOMIZED, MULTICENTRE OPEN LABEL STUDY TO COMPARE THE EFFICACY AND TOLERABILITY OF SOLARAZE® FOR 3 MONTHS VERSUS 6 MONTHS IN PATIENTS WITH MILD TO MODERATE ACTINIC KERATOSIS LOCATED AT THE FACE A... | ||
| Medical condition: Mild to moderate actinic keratoses located at the face and head | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001337-17 | Sponsor Protocol Number: msuspio1muc | Start Date*: 2007-09-25 | |||||||||||
| Sponsor Name:Max-Planck-Institute of Psychiatry | |||||||||||||
| Full Title: Characterisation of multiple sclerosis pathology by “ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques [Charakterisierung der Multipl... | |||||||||||||
| Medical condition: Patients with Multiple Sclerosis (MS, N=90) and patients with a clinically isolated syndrome (ref. to as CIS in literature, i. e. not a clinically definite MS but a syndrome that may occur as first... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2006-001080-38 | Sponsor Protocol Number: ANA 05108 G | Start Date*: 2006-06-01 |
| Sponsor Name:Klinik für Anästhesiologie und Operative Intensivmedizin Klinikum Ludwigshafen | ||
| Full Title: Einfluss einer fischölhaltigen Fettemulsion (SMOF®) auf die systemische immunologische Antwort, die Leberfunktion und die Utilisation bei parenteral ernährten Patienten auf einer chirurgischen Inte... | ||
| Medical condition: Es werden Patienten im Alter > 18 Jahren auf einer chirurgischen Intensivstation, die parenteral ernährt werden müssen, in die Studie eingeschlossen. Ein spezielles Krankheitsbild liegt nicht vor, ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-006037-33 | Sponsor Protocol Number: 150-05 | Start Date*: 2006-08-09 |
| Sponsor Name:Universitätsklinikum Bonn; Klinik und Poliklinik für Psychiatrie und Psychotherapie | ||
| Full Title: Überwachung einer Therapie mit Bromocriptin bei Patienten mit klinisch relevanter Risperidon-induzierter Hyperprolaktinämie. Eine psychiatrisch-endokrinologische Ver-laufsbeobachtung. | ||
| Medical condition: Schizophrene Patienten mit einer Risperidon induzierten Hyperprolaktinämie | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002342-11 | Sponsor Protocol Number: D1449L00033 | Start Date*: 2007-04-19 |
| Sponsor Name:Klinikum Fulda gAG | ||
| Full Title: Multicenter study of neurotransmitters and neuropeptides in schizophrenia: A multidisciplinary study of biological, pharmacokinetic, receptor occupancy and clinical relationships in patients suffer... | ||
| Medical condition: Patients have to fulfill the diagnostic criteria of a schizophrenia according to DSM-IV. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-017869-27 | Sponsor Protocol Number: TERSSC-001 incl. Amendment 1 | Start Date*: 2010-09-23 | |||||||||||
| Sponsor Name:University Hospital Zurich | |||||||||||||
| Full Title: A dual-center, open-label Proof of Concept study to evaluate the efficacy of Terguride for the treatment of fibrosis in patients with systemic sclerosis. | |||||||||||||
| Medical condition: Diffuse scleroderma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-002325-37 | Sponsor Protocol Number: H80-MC-O008 | Start Date*: 2008-07-08 | |||||||||||
| Sponsor Name:Department of Medicine I, University Hospital St. Josef-Hospital, Ruhr University Bochum | |||||||||||||
| Full Title: Effects of Exenatide (Byetta®) on biochemical and histological parameters of liver function in patients with Nonalcoholic Steatohepatitis (NASH) – a randomized, placebo-controlled, parallel-group t... | |||||||||||||
| Medical condition: Non alcoholic steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-001069-32 | Sponsor Protocol Number: D1449L0001 | Start Date*: Information not available in EudraCT |
| Sponsor Name:Psychosis Early Detection and Intervention Centre, Department for Psychiatry, UKE Hamburg | ||
| Full Title: A prospective 8 weeks acute phase-IV study investigating efficacy, safety and tolerability of Quetiapine fumarate in 60 drug-naïve first-episode psychosis patients aged 18 to 35 years | ||
| Medical condition: A prospective 8 weeks acute phase study investigating efficacy, safety and tolerability of Quetiapine fumarate in 60 drug-naïve first-episode psychosis patients aged 18 to 35 years. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000659-18 | Sponsor Protocol Number: FumadermAA01 | Start Date*: 2011-08-22 | |||||||||||
| Sponsor Name:University Hospital Tübingen | |||||||||||||
| Full Title: Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients | |||||||||||||
| Medical condition: Alopecia areata | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.